Introducing
Comprehensive Preclinical Services – Vision of Research
At Vision of Research, we offer a comprehensive suite of research and preclinical services grounded in the deep expertise of our scientific team and powered by cutting-edge biomedical technology and modern laboratory infrastructure. Our mission is to provide accurate, data-driven solutions that address unmet pharmaceutical needs and elevate public health standards.we bridge scientific innovation with clinical reality through our comprehensive preclinical testing and product validation services. Before any therapeutic product reaches the bedside, it must pass through a critical phase of evaluation—where safety, efficacy, and mechanism of action must be proven with scientific precision.
send a message
request a call back
In Vitro & In Vivo
Preclinical Solutions
Preclinical testing involves non-human experiments, including in vitro (lab-based) and in vivo (animal model) studies, to assess a product’s effectiveness and toxicity. This phase includes in vitro tests such as cytotoxicity assessment, mechanism of action studies, and pharmacokinetic (PK) analysis. In vivo testing evaluates toxicology, dose-response relationships, and acute/chronic side effects in animal models. Additionally, pharmacokinetic and pharmacodynamic (PK/PD) studies examine drug absorption, distribution, metabolism, and excretion. For medical devices, mechanical testing, biomaterial compatibility, and biocompatibility assessments are performed.
01 / Toxicology Studies
From acute and sub-chronic toxicity to organ-specific and reproductive toxicity evaluations, we provide GLP-compliant toxicology studies that meet international regulatory standards (FDA, EMA, ICH). Our toxicologists help de-risk your development pathway with clear, reproducible findings.
02 / Dose Optimization & Safety Margins
Our preclinical dose-response studies help define maximum tolerated dose (MTD), no-observed-adverse-effect levels (NOAEL), and therapeutic index, guiding safe and effective dose selection for human trials.
03 / Mechanism & Biomarker Discovery
From acute and sub-chronic toxicity to organ-specific and reproductive toxicity evaluations, we provide GLP-compliant toxicology studies that meet international regulatory standards (FDA, EMA, ICH). Our toxicologists help de-risk your development pathway with clear, reproducible findings.
At Vision of Resarch, product validation represents our scientific commitment to excellence and regulatory compliance. We rigorously demonstrate that every product meets stringent global standards (including FDA, EMA, and ISO requirements) while delivering reliable performance.
This multilayered validation approach ensures our solutions not only comply with regulations but consistently deliver on their intended performance promises. Through these meticulous processes, we build trust with healthcare providers, regulators, and patients alike.
Leveraging advanced in vitro and in vivo platforms, our solutions are designed to precisely validate the safety, efficacy, and quality of pharmaceutical, cosmetic, and nutraceutical products before entering clinical trial phases.
Ultimately, preclinical testing and product validation are essential steps—without them, no drug or medical device can gain market approval. These processes ensure safety, efficacy, and compliance with quality and regulatory standards. If you need further details on specific testing methods or standards, I’d be happy to provide additional information